The drug monosodium luminol (GVT®) preserves thymic epithelial cell cytoarchitecture and allows thymocyte survival in mice infected with the T cell-tropic, cytopathic retrovirus ts1

Immunology Letters

Volumn 122, Issue 2, 2009, Pages 159-169

  Scofield, Virginia L ^a   Yan, Mingshan ^a   Kuang, Xianghong ^a   Kim, Soo Jin ^a   Crunk, Derek ^a   Wong, Paul K Y ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

GVT; Oxidative stress; Thymus

Indexed keywords

ANTIOXIDANT; BETA ACTIN; CASPASE 3; CYTOKERATIN 5; CYTOKERATIN 8; GVT; MONOSODIUM LUMINOL; PROTEIN PRECURSOR; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL DISRUPTION; CELL LOSS; CELL PROTECTION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONNECTIVE TISSUE; CONTROLLED STUDY; CYTOARCHITECTURE; CYTOPATHOGENIC EFFECT; DEATH; DENDRITIC CELL; EPITHELIUM CELL; FIBROBLAST; MACROPHAGE; MOLECULAR STABILITY; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRE T LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS INFECTION; T LYMPHOCYTE; THYMOCYTE; THYMUS; THYMUS ATROPHY; UPREGULATION; VIRUS REPLICATION; WASTING SYNDROME;

ANIMALS; ANTIOXIDANTS; CD4-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; CYTOPATHOGENIC EFFECT, VIRAL; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, VIRAL; IMMUNE TOLERANCE; KERATINS; LEUKEMIA VIRUS, MURINE; LEUKEMIA, EXPERIMENTAL; MICE; MUTATION; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; RETROVIRIDAE INFECTIONS; RETROVIRIDAE PROTEINS; THYMUS GLAND;

EID: 61849140070     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2008.12.009     Document Type: Article

References (97)

1. Barth C.F., Ewert D.L., Olson W.C., and Humphries E.H. Reticuloendotheliosis virus REVT(REV-A)-induced neoplasia: development of tumors within the T-lymphoid and myeloid lineages. J Virol 64 (1990) 6054-6062
2. O'Neill H.C. The diversity of retroviral diseases of the immune system. Immunol Cell Biol 70 Pt 3 (1992) 193-199
3. Tompkins M.B., and Tompkins W.A. Lentivirus-induced immune dysregulation. Vet Immunol Immunopathol 123 (2008) 45-55
4. + T cells are rapidly eliminated in early SIV infection in vivo. J Virol 74 (2000) 57-64
5. Panda B.R., Kingsman S.M., and Kingsman A.J. Mutational analysis of the putative receptor binding domain of Moloney murine leukemia virus glycoprotein gp70. Virology 273 (2000) 90-100
6. 114/simian type D retrovirus receptor is a neutral amino acid transporter. Proc Natl Acad Sci USA 96 (1999) 2129-2134
7. Reggeti F., Ackerley C., and Bienzle D. CD134 and CXCR4 expression corresponds to feline immunodeficiency virus infection of lymphocytes, macrophages and dendritic cells. J Gen Virol 89 (2008) 277-287
8. Bonzon C., and Fan H. Moloney murine leukemia virus-induced preleukemic thymic atrophy and enhanced thymocyte apoptosis correlate with disease pathogenicity. J Virol 73 (1999) 2434-2441
9. El-Far M., Halwani R., Said E., Trautmann L., Doroudchi M., Janbazian L., et al. T-cell exhaustion in HIV infection. Curr HIV/AIDS Rep 5 (2008) 13-19
10. Ho Tsong Fang R., Colantonio A.D., and Uittenbogaart C.H. The role of the thymus in HIV infection: a 10 year perspective. AIDS 22 (2008) 171-184
11. Marmor M.D., Benatar T., and Ratcliffe M.J. Retroviral transformation in vitro of chicken T cells expressing either/or γ/δ T cell receptors by reticuloendotheliosis virus strain T. J Exp Med 177 (1993) 647-656
12. + regulatory T cells are infected and activated during acute FIV infection. Vet Immunol Immunopathol (2008)
13. Prukova D., Vernerova Z., Pilcik T., Stepanets V., Indrova M., Geryk J., et al. Differences in pathogenicity among strains of the same or different avian leukosis virus subgroups. Avian Pathol 36 (2007) 15-27
14. + T cells in natural SIV infection. PLoS Pathog 4 (2008) e1000107
15. Wong P.K., and McCarter J.A. Genetic studies of temperature-sensitive mutants of Moloneymurine leukemia virus. Virology 53 (1973) 319-326
16. Wong P.K., Szurek P.F., Floyd E., Saha K., and Brooks B.R. Alteration from T- to B-cell tropism reduces thymic atrophy and cytocidal effects in thymocytes but not neurovirulence induced by ts1, a mutant of Moloney murine leukemia virus TB. Proc Natl Acad Sci USA 88 (1991) 8991-8995
17. Chakraborty J., Clark S., Okonta H., and Duggan J. A small animal model for mother-to-fetus transmission of ts1, a murine retrovirus. Viral Immunol 16 (2003) 191-201
18. Clark S., Duggan J., and Chakraborty J. ts1 and LP-BM5: a comparison of two murine retrovirus models for HIV. Viral Immunol 14 (2001) 95-109
19. + T cells in order to cause paralysis and immunodeficiency. J Virol 66 (1992) 2639-2646
20. Stoica G., Floyd E., Illanes O., and Wong P.K. Temporal lymphoreticular changes caused by ts1, a paralytogenic mutant of Moloney murine leukemia virus TB. Lab Invest 66 (1992) 427-436
21. Wong P.K.Y., Lynn W.S., Lin Y.C., Choe W., and Yuen P.H. ts1-MoMuLV: a murine model of neuroimmunodegeneration. Neuroimmunodegeneration (1998) 75-93
22. Saha K., and Wong P.K. T, not B, lymphocytes are required for immunodeficiency and paralysis induced by ts1, a mutant of Moloney murine leukemia virus-TB. Virology 183 (1991) 815-820
23. Saha K., Yuen P.H., and Wong P.K. Murine retrovirus-induced depletion of T cells is mediated through activation-induced death by apoptosis. J Virol 68 (1994) 2735-2740
24. Wong P.K., Prasad G., Hansen J., and Yuen P.H. ts1, a mutant of Moloney murine leukemia virus-TB, causes both immunodeficiency and neurologic disorders in BALB/c mice. Virology 170 (1989) 450-459
25. Gonzales-Scarano F., Nathanson N., and Wong P.K.Y. Retroviruses and the nervous system. In: Levy J.A. (Ed). The retroviridae (1995), Plenum Press, New York, NY 409-490
26. env, and neurovirulence of ts1, a mutant of Moloney murine leukemia virus TB. J Virol 64 (1990) 467-475
27. Kamps C.A., Lin Y.-C., and Wong P.K.Y. Oligomerization and transport of the envelope protein of Moloney murine leukemia virus-TB and of ts1, a neurovirulent temperature-sensitive mutant of MoMuLV-TB. Virology 184 (1991) 687-694
28. Yu Y., and Wong P.K. Studies on compartmentation and turnover of murine retrovirus envelope proteins. Virology 188 (1992) 477-485
29. Jiang Y., Scofield V.L., Yan M., Qiang W., Liu N., Reid A.J., et al. Retrovirus-induced oxidative stress with neuroimmunodegeneration is suppressed by antioxidant treatment with a refined monosodium α-luminol (Galavit). J Virol 80 (2006) 4557-4569
30. Kim H.T., Qiang W., Wong P.K., and Stoica G. Enhanced proteolysis of IκBα and IκBβ proteins in astrocytes by Moloney murine leukemia virus (MoMuLV)-ts1 infection: a potential mechanism of NF-κB activation. J Neurovirol 7 (2001) 466-475
31. Kim H.T., Tasca S., Qiang W., Wong P.K., and Stoica G. Induction of p53 accumulation by Moloney murine leukemia virus-ts1 infection in astrocytes via activation of extracellular signal-regulated kinases 1/2. Lab Invest 82 (2002) 693-702
32. Kim H.T., Waters K., Stoica G., Qiang W., Liu N., Scofield V.L., et al. Activation of endoplasmic reticulum stress signaling pathway is associated with neuronal degeneration in MoMuLV-ts1-induced spongiform encephalomyelopathy. Lab Invest 84 (2004) 816-827
33. Kim H.T., Qiang W., Liu N., Scofield V.L., Wong P.K., and Stoica G. Up-regulation of astrocyte cyclooxygenase-2, CCAAT/enhancer-binding protein-homology protein, glucose-related protein 78, eukaryotic initiation factor 2α, and c-Jun N-terminal kinase by a neurovirulent murine retrovirus. J Neurovirol 11 (2005) 166-179
34. Liu N., Qiang W., Kuang X., Thuillier P., Lynn W.S., and Wong P.K. The peroxisome proliferator phenylbutyric acid (PBA) protects astrocytes from ts1 MoMuLV-induced oxidative cell death. J Neurovirol 8 (2002) 318-325
35. Liu N., Kuang X., Kim H.T., Stoica G., Qiang W., Scofield V.L., et al. Possible involvement of both endoplasmic reticulum- and mitochondria-dependent pathways in MoMuLV-ts1- induced apoptosis in astrocytes. J Neurovirol 10 (2004) 189-198
36. Liu N., Scofield V.L., Qiang W., Yan M., Kuang X., and Wong P.K. Interaction between endoplasmic reticulum stress and caspase 8 activation in retrovirus MoMuLV-ts1-infected astrocytes. Virology 348 (2006) 398-405
37. Qiang W., Cahill J.M., Liu J., Kuang X., Liu N., Scofield V.L., et al. Activation of transcription factor Nrf-2 and its downstream targets in response to Moloney murine leukemia virus ts1-induced thiol depletion and oxidative stress in astrocytes. J Virol 78 (2004) 11926-11938
38. Qiang W., Kuang X., Liu J., Liu N., Scofield V., Stoica G., et al. Astrocytes survive chronic infection and cytopathic effects of the ts1 mutant of the retrovirus Moloney murine leukemia virus by upregulation of antioxidant defenses. J Virol 80 (2006) 3273-3284
39. Lungu G.F., Stoica G., and Wong P.K.Y. Down-regulation of Jab1, HIF-1a, and VEGF by Moloney murine leukemia virus-ts1 infection: a possible cause of neurodegeneration. J Neurovirol 14 (2008) 239-251
40. Suzuki Y.J., Forman H.J., and Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med 22 (1997) 269-285
41. Day R.M., and Suzuki Y.J. Cell proliferation, reactive oxygen and cellular glutathione. Dose Response 3 (2005) 425-442
42. Winterbourn C.C., and Hampton M.B. Thiol chemistry and specificity in redox signaling. Free Radic Biol Med 45 (2008) 549-561
43. Moi P., Chan K., Asunis I., Cao A., and Kan Y.W. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NFE2/AP1 repeat of the β-globin locus control region. Proc Natl Acad Sci USA 91 (1994) 9926-9930
44. Lau A., Villeneuve N.F., Sun Z., Wong P.K., and Zhang D.D. Dual roles of Nrf2 in cancer. Pharmacol Res (2008)
45. Boehm T. Thymus development and function. Curr Opin Immunol 20 (2008) 178-184
46. Rodewald H.R. Thymus organogenesis. Annu Rev Immunol 26 (2008) 355-388
47. Li B., Gladden A.D., Altfeld M., Kaldor J.M., Cooper D.A., Kelleher A.D., et al. Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution. J Virol 81 (2007) 193-201
48. Zlotoff D.A., Schwarz B.A., and Bhandoola A. The long road to the thymus: the generation, mobilization, and circulation of T-cell progenitors in mouse and man. Semin Immunopathol (2008) [Epub ahead of print]
49. Klug D.B., Carter C., Crouch E., Roop D., Conti C.J., and Richie E.R. Interdependence of cortical thymic epithelial cell differentiation and T-lineage commitment. Proc Natl Acad Sci USA 95 (1998) 11822-11827
50. Klug D.B., Crouch E., Carter C., Coghlan L., Conti C.J., and Richie E.R. Transgenic expression of cyclin D1 in thymic epithelial precursors promotes epithelial and T cell development. J Immunol 164 (2000) 1881-1888
51. Minter L.M., and Osborne B.A. Cell death in the thymus-it' s all a matter of contacts. Semin Immunol 15 (2003) 135-144
52. LeBel C.P., Ali S.F., McKee M., and Bondy S.C. Organometal-induced increases in oxygen reactive species: the potential of 2′,7′-dichlorofluorescein diacetate as an index of neurotoxic damage. Toxicol Appl Pharmacol 104 (1990) 17-24
53. Alam J., Killeen E., Gong P., Naquin R., Hu B., Stewart D., et al. Heme activates the heme oxygenase-1 gene in renal epithelial cells by stabilizing Nrf2. Am J Physiol Renal Physiol 284 (2003) F743-752
54. Nguyen T., Yang C.S., and Pickett C.B. The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. Free Radic Biol Med 37 (2004) 433-441
55. Zhang D.D., and Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol 23 (2003) 8137-8151
56. Purdom-Dickinson S.E., Sheveleva E.V., Sun H., and Chen Q.M. Translational control of Nrf2 protein in activation of antioxidant response by oxidants. Mol Pharmacol 72 (2007) 1074-1081
57. Gharavi N., Haggarty S., and El-Kadi A.O. Chemoprotective and carcinogenic effects of tertbutylhydroquinone and its metabolites. Curr Drug Metab 8 (2007) 1-7
58. H1 immunity: role of dendritic cells. J Allergy Clin Immunol 121 1255-1261 (2008) e1257
59. -/-, and Hoxa3,Pax1 mutant mice. BMC Immunol 3 (2002) 12
60. NTR-dependent motor neuron apoptosis. J Neurochem 97 (2006) 687-696
61. Wong P.K.Y., Saha K., Lin Y.-C., Lynn W.S., and Yuen P.H. Long term cultivation and productive infection of primary thymocyte cultures by a thymocytopathic murine retrovirus. Virology 215 (1996) 203-206
62. Rothe M., Chene L., Nugeyre M.T., Braun J., Barre-Sinoussi F., and Israel N. Contact with thymic epithelial cells as a prerequisite for cytokine-enhanced human immunodeficiency virus type 1 replication in thymocytes. J Virol 72 (1998) 5852-5861
63. Ushioda R., Hoseki J., Araki K., Jansen G., Thomas D.Y., and Nagata K. ERdj5 is required as a disulfide reductase for degradation of misfolded proteins in the ER. Science 321 (2008) 569-572
64. Johnson C.M., Bortnick S.J., Crawford P.C., and Papadi G.P. Unique susceptibility of the fetal thymus to feline immunodeficiency virus infection: an animal model for HIV infection in utero. Am J Reprod Immunol 45 (2001) 273-288
65. Muller J.G., Krenn V., Czub S., Stahl-Hennig C., Coulibaly C., Hunsmann G., et al. The thymic epithelial reticulum and interdigitating cells in SIV-induced thymus atrophy and its comparison with other forms of thymus involution. Res Virol 144 (1993) 93-98
66. + T-cells despite suppression of HIV replication under HAART. AIDS Rev 8 (2006) 88-97
67. Goldberg G.L., Zakrzewski J.L., Perales M.A., and van den Brink M.R. Clinical strategies to enhance T cell reconstitution. Semin Immunol 19 (2007) 289-296
68. van den Brink M.R., Alpdogan O., and Boyd R.L. Strategies to enhance T-cell reconstitution in immunocompromised patients. Nat Rev Immunol 4 (2004) 856-867
69. Butorov I.V., Nikolenko I.A., and Butorov S.I. Efficacy of galavit in patients with duodenal ulcer. Klin Med (Mosk) 83 (2005) 72-75
70. Nelyubov M.V. Cytokins in the pathogenesis of astrakhan spotted fever and North Asian scrub typhus: problems of immunocorrection. Bull Exp Biol Med 134 (2002) 165-167
71. Shaplygin L.V., and Klopot A.M. The efficiency of the drug "Galavit" in complex treatment for infectious and inflammatory diseases of the urogenital system. Voen Med Zh 327 (2006) 29-34
72. Sukhorukov A.L. Galavit efficiency in prophylaxis and treatment of pyo-inflammatory complications at abdominal surgical pathology. Voen Med Zh 326 (2005) 31-33
73. Vyshegurov I., Anikhovskaia I.A., Batmanov Iu E., and Iakovlev M. Intestinal endotoxin in the pathogenesis of ocular inflammatory diseases and the antiendoxin constituent of its treatment. Patol Fiziol Eksp Ter (2007) 12-14
74. Prasad G., Stoica G., and Wong P.K.Y. The role of the thymus in the pathogenesis of hind-limb paralysis induced by ts1, a mutant of Moloney murine leukemia virus-TB. Virology 169 (1989) 332-340
75. Crise B., Buonocore L., and Rose J.K. CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor. J Virol 64 (1990) 5585-5593
76. Li Y., Luo L., Thomas D.Y., and Kang C.Y. The HIV-1 Env protein signal sequence retards its cleavage and down-regulates the glycoprotein folding. Virology 272 (2000) 417-428
77. - human cell lines. J Virol 46 (1990) 4661-4671
78. Land A., Zonneveld D., and Braakman I. Folding of HIV-1 envelope glycoprotein involves extensive isomerization of disulfide bonds and conformation-dependent leader peptide cleavage. FASEB J 17 (2003) 1058-1067
79. + lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection. Blood 86 (1995) 258-267
80. Aukrust P., Muller F., Svardal A.M., Ueland T., Berge R.K., and Froland S.S. Disturbed glutathione metabolism and decreased antioxidant levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy-potential immunomodulatory effects of antioxidants. J Infect Dis 188 (2003) 232-238
81. Baier-Bitterlich G., Wachter H., and Fuchs D. Oxidative stress and apoptosis in HIV infection. Science 271 (1996) 582-583
82. Baruchel S., and Wainberg M.A. The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus. J Leukoc Biol 52 (1992) 111-114
83. + lymphocytes from human immunodeficiency virus-infected individuals. Blood 87 (1996) 4746-4753
84. Dobmeyer T.S., Findhammer S., Dobmeyer J.M., Klein S.A., Raffel B., Hoelzer D., et al. Ex vivo induction of apoptosis in lymphocytes is mediated by oxidative stress: role for lymphocyte loss in HIV infection. Free Radic Biol Med 22 (1997) 775-785
85. Gil L., Martinez G., Gonzalez I., Tarinas A., Alvarez A., Giuliani A., et al. Contribution to characterization of oxidative stress in HIV/AIDS patients. Pharmacol Res 47 (2003) 217-224
86. Gulow K., Kaminski M., Darvas K., Suss D., Li-Weber M., and Krammer P.H. HIV-1 transactivator of transcription substitutes for oxidative signaling in activation-induced T cell death. J Immunol 174 (2005) 5249-5260
87. Karamchand L., Dawood H., and Chuturgoon A.A. Lymphocyte mitochondrial depolarization and apoptosis in HIV-1-infected HAART patients. J Acquir Immune Defic Syndr 48 (2008) 381-388
88. Losa G.A., and Graber R. Spontaneous apoptosis, oxidative status and immunophenotype markers in blood lymphocytes of AIDS patients. Anal Cell Pathol 21 (2000) 11-20
89. Moretti S., Famularo G., Marcellini S., Boschini A., Santini G., Trinchieri V., et al. L-carnitine reduces lymphocyte apoptosis and oxidant stress in HIV-1-infected subjects treated with zidovudine and didanosine. Antioxid Redox Signal 4 (2002) 391-403
90. Perl A., and Banki K. Genetic and metabolic control of the mitochondrial transmembrane potential and reactive oxygen intermediate production in HIV disease. Antioxid Redox Signal 2 (2000) 551-573
91. Piette J., and Legrand-Poels S. HIV-1 reactivation after an oxidative stress mediated by different reactive oxygen species. Chem Biol Interact 91 (1994) 79-89
92. Sandstrom P.A., Roberts B., Folks T.M., and Buttke T.M. HIV gene expression enhances T cell susceptibility to hydrogen peroxide-induced apoptosis. AIDS Res Hum Retroviruses 9 (1993) 1107-1113
93. Sappey C., Legrand-Poels S., Best-Belpomme M., Favier A., Rentier B., and Piette J. Stimulation of glutathione peroxidase activity decreases HIV type 1 activation after oxidative stress. AIDS Res Hum Retroviruses 10 (1994) 1451-1461
94. Burckhardt C.J., and Greber U.F. Redox rescues virus from ER trap. Nat Cell Biol 10 (2008) 9-11
95. + epithelial cell progenitors and by increased expression of Trp63, cMyc and Tcf3 transcription factors in the thymic stroma. Int Immunol 19 (2007) 1249-1260
96. Ribeiro R.M., and de Boer R.J. The contribution of the thymus to the recovery of peripheral naive T-cell numbers during antiretroviral treatment for HIV infection. J Acquir Immune Defic Syndr 49 (2008) 1-8
97. Scofield VL, Yan MS, Kuang X, Kim SJ, Wong PKY. The drug monosodium luminol (GVT) preserves crypt-villus epithelial organization and allows survival of intestinal T cells in mice infected with the ts1 retrovirus. Immunol Lett 2009, this issue.